Search Results 141-150 of 17271 for protein intake optimization

1. Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... generation sequencing or absence of MTAP protein in a tumor detected by IHC. ... requirements 3 ...

2. Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... Specific laboratory requirements for Step 2 must be obtained within 2 weeks prior to Step 2 randomization.

3. Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... Specific laboratory requirements for Step 2 must be obtained within 2 weeks prior to Step 2 randomization.

4. Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... Note: Patients with IgA myeloma in whom serum protein ... This requirement can be met in several different ways ...

5. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... The presence of measurable disease and a M protein ≥1 g/dL is not necessary. ... requirement for this disease, ...

6. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... Previously treated with a mitogen-activated protein kinase kinase (MEK) inhibitor ... Psychiatric illness/ ...

7. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... protein in 24 hours; Negative pregnancy test done ... requirements; Receiving any other ...

8. Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radiation Injury After Treatment for Brain Metastases - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... 24-hour urine protein must be <1000 mg. Able to ... requirements. No history of serious non ...

9. Counting calories: Get back to weight-loss basics - Mayo Clinic

   Carbohydrates, fats and proteins are the types of ... Optimal diet strategies for weight loss and weight loss maintenance. ... Admissions Requirements · Degree ...

10. PRT3789 Monotherapy And In Combo W/Docetaxel In Participants W/Advanced Or Metastatic Solid Tumors W/SMARCA4 Mutation - Mayo Clinic

    Participants with solid tumors with known concomitant SMARCA2 mutation or loss of protein expression * Clinically significant or uncontrolled cardiac ...